Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

Standard

Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. / Hagel, Stefan; Bach, Friedhelm; Brenner, Thorsten; Bracht, Hendrik; Brinkmann, Alexander; Annecke, Thorsten; Hohn, Andreas; Weigand, Markus Alexander; Michels, Guido; Kluge, Stefan; Nierhaus, Axel; Jarczak, Dominik; König, Christina; Weismann, Dirk; Frey, Otto; Witzke, Dominic; Müller, Carsten; Bauer, Michael; Kiehntopf, Michael; Neugebauer, Sophie; Lehmann, Thomas; Roberts, Jason A; Pletz, Mathias W; TARGET Trial Investigators.

In: INTENS CARE MED, Vol. 48, No. 5, 05.2022, p. 646-647.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

Hagel, S, Bach, F, Brenner, T, Bracht, H, Brinkmann, A, Annecke, T, Hohn, A, Weigand, MA, Michels, G, Kluge, S, Nierhaus, A, Jarczak, D, König, C, Weismann, D, Frey, O, Witzke, D, Müller, C, Bauer, M, Kiehntopf, M, Neugebauer, S, Lehmann, T, Roberts, JA, Pletz, MW & TARGET Trial Investigators 2022, 'Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial', INTENS CARE MED, vol. 48, no. 5, pp. 646-647. https://doi.org/10.1007/s00134-022-06668-3

APA

Hagel, S., Bach, F., Brenner, T., Bracht, H., Brinkmann, A., Annecke, T., Hohn, A., Weigand, M. A., Michels, G., Kluge, S., Nierhaus, A., Jarczak, D., König, C., Weismann, D., Frey, O., Witzke, D., Müller, C., Bauer, M., Kiehntopf, M., ... TARGET Trial Investigators (2022). Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. INTENS CARE MED, 48(5), 646-647. https://doi.org/10.1007/s00134-022-06668-3

Vancouver

Bibtex

@article{bc845a2835a94113bafd371f2c053c39,
title = "Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial",
author = "Stefan Hagel and Friedhelm Bach and Thorsten Brenner and Hendrik Bracht and Alexander Brinkmann and Thorsten Annecke and Andreas Hohn and Weigand, {Markus Alexander} and Guido Michels and Stefan Kluge and Axel Nierhaus and Dominik Jarczak and Christina K{\"o}nig and Dirk Weismann and Otto Frey and Dominic Witzke and Carsten M{\"u}ller and Michael Bauer and Michael Kiehntopf and Sophie Neugebauer and Thomas Lehmann and Roberts, {Jason A} and Pletz, {Mathias W} and {TARGET Trial Investigators}",
year = "2022",
month = may,
doi = "10.1007/s00134-022-06668-3",
language = "English",
volume = "48",
pages = "646--647",
journal = "INTENS CARE MED",
issn = "0342-4642",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

AU - Hagel, Stefan

AU - Bach, Friedhelm

AU - Brenner, Thorsten

AU - Bracht, Hendrik

AU - Brinkmann, Alexander

AU - Annecke, Thorsten

AU - Hohn, Andreas

AU - Weigand, Markus Alexander

AU - Michels, Guido

AU - Kluge, Stefan

AU - Nierhaus, Axel

AU - Jarczak, Dominik

AU - König, Christina

AU - Weismann, Dirk

AU - Frey, Otto

AU - Witzke, Dominic

AU - Müller, Carsten

AU - Bauer, Michael

AU - Kiehntopf, Michael

AU - Neugebauer, Sophie

AU - Lehmann, Thomas

AU - Roberts, Jason A

AU - Pletz, Mathias W

AU - TARGET Trial Investigators

PY - 2022/5

Y1 - 2022/5

U2 - 10.1007/s00134-022-06668-3

DO - 10.1007/s00134-022-06668-3

M3 - Other (editorial matter etc.)

C2 - 35303118

VL - 48

SP - 646

EP - 647

JO - INTENS CARE MED

JF - INTENS CARE MED

SN - 0342-4642

IS - 5

ER -